Breast Implant Revision
0
Pipeline Programs
1
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
BellaSenoGermany - Leipzig
3 programsImplantation of the PCL Breast scaffold with autologous fat graftingN/A1 trial
LTFU of PCL Breast Scaffolds Used in 2021-BRV-004N/A1 trial
Surgical implantation of the PCL Breast scaffold with autologous fat graftingN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
BellaSenoLTFU of PCL Breast Scaffolds Used in 2021-BRV-004
BellaSenoImplantation of the PCL Breast scaffold with autologous fat grafting
BellaSenoSurgical implantation of the PCL Breast scaffold with autologous fat grafting
Clinical Trials (3)
Total enrollment: 125 patients across 3 trials
LTFU of PCL Breast Scaffolds Used in 2021-BRV-004
Start: Nov 2026Est. completion: Feb 202919 patients
N/ANot Yet Recruiting
Scaffold-guided Breast Implant Revision and Primary Breast Augmentation Surgery
Start: Feb 2026Est. completion: Jan 203287 patients
N/ARecruiting
Scaffold-guided Breast Surgery
Start: Jun 2022Est. completion: Dec 202519 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 125 patients
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.